Condition: Hepatitis C, Chronic · Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
To determine the treatment efficacy, safety and long-term outcomes of chronic hepatitis C patients receiving directly acting antivirals in Taiwan
This description comes directly from the study's public registry record.
Ming-Lung Yu, MD., PhD · 88673121101 · fish6069@gmail.com
Always discuss trial participation with your own doctor first.
| HepatobiliaryDivision, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan | Kaohsiung City, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03200379